Bayer presented the latest progress in the ongoing transformation of its pharmaceutical business focusing on accelerating innovative healthcare solutions for the benefits of patients and delivering long-term, sustainable business growth at its annual Pharma Media Day 2023 organised recently in Berlin.
Share this article
Share this article
ResearchAndMarkets.com s offering.
This report examines the market for these vaccines used to prevent various types of disease, and provides market modeling by disease.
Seven billion dollars in new sales have occurred in the past five years alone, and vaccines have been developed and deployed for new diseases. New vaccines are under development.
It focuses on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. The report also discusses trends and looks at what vaccine companies have done and are planning. It also covers the COVID-19 vaccine market landscape, development progress and estimated market opportunity as of October 2020.